Mariner, LLC Vertex Pharmaceuticals Inc Transaction History

Mariner, LLC

$51.1 Billion
Q2 2024

A detailed history of Mariner, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Mariner, LLC holds 121,412 shares of VRTX stock, worth $61 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

121,412

Previous 115,461 5.15%

Holding current value

$61 Million

Previous $48.3 Million 17.91%

% of portfolio

0.11%

Previous 0.1%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$392.81 - $485.53 $2.34 Million - $2.89 Million	5,951 Added 5.15%	121,412 $56.9 Million
Q1 2024 May 15, 2024	BUY	$407.69 - $446.08 $2.66 Million - $2.91 Million	6,518 Added 5.98%	115,461 $48.3 Million
Q4 2023 Feb 14, 2024	BUY	$343.0 - $410.68 $4.23 Million - $5.06 Million	12,331 Added 12.76%	108,943 $44.3 Million
Q3 2023 Nov 13, 2023	BUY	$338.18 - $362.46 $1.14 Million - $1.23 Million	3,382 Added 3.63%	96,612 $33.6 Million
Q2 2023 Aug 11, 2023	BUY	$314.42 - $351.91 $574,759 - $643,291	1,828 Added 2.0%	93,230 $32.8 Million
Q1 2023 May 12, 2023	BUY	$283.23 - $323.1 $16.9 Million - $19.3 Million	59,637 Added 187.74%	91,402 $28.8 Million
Q4 2022 Feb 14, 2023	BUY	$285.76 - $321.48 $3.72 Million - $4.19 Million	13,022 Added 69.48%	31,765 $9.2 Million
Q3 2022 Nov 10, 2022	BUY	$273.83 - $305.53 $1.99 Million - $2.22 Million	7,262 Added 63.25%	18,743 $5.43 Million
Q2 2022 Aug 15, 2022	BUY	$234.96 - $292.55 $108,081 - $134,573	460 Added 4.17%	11,481 $3.24 Million
Q1 2022 May 13, 2022	BUY	$221.42 - $260.97 $2.44 Million - $2.88 Million	11,021 New	11,021 $2.88 Million
Q3 2019 Nov 13, 2019	SELL	$166.23 - $187.09 $216,431 - $243,591	-1,302 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$164.61 - $190.37 $6,419 - $7,424	39 Added 3.09%	1,302 $239,000
Q1 2019 May 15, 2019	BUY	$163.73 - $194.7 $206,790 - $245,906	1,263 New	1,263 $232,000

Others Institutions Holding VRTX

# of Institutions

1,716

Shares Held

225M

Call Options Held

1.19M

Put Options Held

1.56M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $129B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mariner, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mariner, LLC with notifications on news.

Account